Sept 21 (Reuters) - Indian chemicals maker Epigral (EPIG.NS) will keep diversifying its business and expects the share of revenue from new products to expand significantly this year, its chairman and managing director told Reuters on Thursday.
At that time, we were catering to seven industries," Maulik Patel told the Reuters Trading India forum.
The specialty chemicals market represents 22% of India's overall chemicals and petrochemicals market and is valued at $32 billion, according to KPMG.
It exports its products to more than 20 countries including South Africa and the United States.
(Join Trading India, a chat room hosted on Refinitiv Messenger: https://bit.ly/3TNDwkC)($1 = 83.0434 Indian rupees)Reporting by Savio Shetty; Editing by Sonia CheemaOur Standards: The Thomson Reuters Trust Principles.
Persons:
Maulik Patel, Patel, Epigral, Savio Shetty, Sonia Cheema
Organizations:
Reuters, Reuters Trading, KPMG, Thomson
Locations:
Gujarat, Reuters Trading India, India, Ahmedabad, South Africa, United States